Skip to main navigation
Skip to search
Skip to main content
Albert Einstein College of Medicine Home
Home
Faculty
Departments
Grants
Publications
Prizes
Search by expertise, name or affiliation
Cardiac toxicity of trastuzumab (Herceptin): implications for the design of adjuvant trials.
J. A. Sparano
Medicine
Research output
:
Contribution to journal
›
Review article
›
peer-review
81
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Cardiac toxicity of trastuzumab (Herceptin): implications for the design of adjuvant trials.'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Trastuzumab
100%
Cardiotoxicity
95%
Doxorubicin
38%
Anthracyclines
23%
Paclitaxel
21%
San Francisco
13%
Oncogenes
9%
Monoclonal Antibodies
7%
Breast Neoplasms
6%
Safety
6%
Incidence
5%
Wounds and Injuries
5%
Therapeutics
3%